Taiho’s Lytgobi Faces Heavy Competition, But Sets Efficacy Bar For Now

 
• By Alaric DeArment
  
Taiho Oncology won approval for Lytgobi in intrahepatic cholangiocarcinoma • Source: Shutterstock

More from New Products

More from Scrip